Clinical Updates

Health regulators approved Vertex Pharmaceuticals’ Kalydeco, the first drug designed to treat the underlying cause of cystic fibrosis, a rare… »   

Orexigen Therapeutics Inc said it reached an agreement with U.S. health regulators on the design of a heart-safety trial required… »   

Reviewers from the U.S. Food and Drug Administration said on Monday that they were not sure whether Amgen Inc’s Xgeva… »   

An open-label study of rituximab, a monoclonal antibody for human CD20, was shown to be safe in patients with primary… »   

An experimental drug, clazosentan, reduced the risk of blood vessel spasm in patients with a brain aneurysm, according to research… »   

A new study published in the journal Pharmacoepidemiology & Drug Safety reveals that internet sites selling prescription statins directly to… »   

The first drug that treats an underlying cause of cystic fibrosis, rather than just the symptoms, was approved by the… »   

Adults with metastatic basal cell cancer now have a new drug to help them battle the disease.

The Food and… »   

In patients undergoing hip replacement surgery, using a special wound catheter to infuse local anesthetic directly into the hip joint… »   

Researchers at the University of Southampton, University of Oxford and Retroscreeen Virology Ltd have discovered a series of peptides, found… »   

U.S. health regulators on Monday approved Roche’s pill to treat an advanced form of the most common form of skin… »   

Scientists in Trinity College Dublin, Ireland, have developed a new vaccine to treat cancer at the pre-clinical level. The research… »   

Johnson & Johnson on Friday said it is recalling more than 2,000 tubes of its Aveeno Baby Calming Comfort Lotion… »   

A new system for delivering a drug to organ transplant patients, which could avoid the risk of harmful side effects,… »   

Gardasil, the human papillomavirus vaccine that is now recommended for male and female adolescents and young adults, does not trigger… »